The effects of oral pretreatment with zofenopril, an angiotensin-converting enzyme inhibitor, on early reperfusion and subsequent electrophysiologic stability in the pig
- 1 May 1990
- journal article
- conference paper
- Published by Springer Nature in Cardiovascular Drugs and Therapy
- Vol. 4 (3) , 695-703
- https://doi.org/10.1007/bf01856557
Abstract
The effects of oral zofenopril pretreatment were investigated in a chronic closed-chest pig model of ischemia and reperfusion. Pigs (25–35 kg) were pretreated orally with zofenopril (15 mg/day) on the 2 days prior to ischemia, which was evoked by the inflation of a catheter balloon in the left anterior descending coronary artery over 45 minutes. The catheter was then removed and the myocardium was reperfused. After 2 weeks, infarct properties were assessed by signal averaging of the body surface electrocardiogram and the inducibility of malignant ventricular tachyarrhythmias was tested with a programmed electrical stimulation protocol. A significant increase in the pressure-rate product (43±11%, mean±SEM), indicating the oxygen demand of the heart, was prevented by zofenopril (19±8%, p<0.05). Zofenopril reduced the peak efflux of adrenaline (1302±213 vs. 3201±760 pg/ml; p<0.05), noradrenaline (402±54 vs. 902±282 pg/ml; p<0.05), and of the adenosine catabolites inosine and hypoxanthine (56±4 vs. 78±9, pg/ml; p<0.05) in the coronary venous effluent. The efflux of the cytoplasmatic enzyme creatine phosphokinase was not significantly reduced after zofenopril (p=0.08). No difference in plasma renin levels between the groups were found. After 2 weeks, late potentials were found only in the surviving animals from the untreated group, i.e., the voltage vector magnitude was more reduced, and a prolongation of the QRS duration and of the terminal low-amplitude part of the high-frequency QRS were found. Moreover, zofenopril had caused a significant reduction of the inducibility of sustained ventricular tachyarrhythmias. These findings support the view that catecholamine and purine efflux, and an adverse increase in the oxygen demand during early reperfusion are reduced by zofenopril pretreatment, leading to a higher electrophysiologic stability of the subsequently developed infarct after 2 weeks.Keywords
This publication has 31 references indexed in Scilit:
- Preclinical Pharmacology of Zofenopril, an Inhibitor of Angiotensin I Converting EnzymeJournal of Cardiovascular Pharmacology, 1989
- Effects of Angiotensin II and Captopril on Inducible Sustained Ventricular Tachycardia Two Weeks After Myocardial Infarction in the PigJournal of Cardiovascular Pharmacology, 1989
- The protection of the ischemic myocardium: Surgical success v clinical failure?Progress in Cardiovascular Diseases, 1988
- Usefulness of the accelerated idioventricular rhythm as a marker for myocardial necrosis and reperfusion during thrombolytic therapy in acute myocardial infarctionThe American Journal of Cardiology, 1988
- Interventions that potentially limit myocardial infarct size: Overview of clinical trialsThe American Journal of Cardiology, 1987
- Concentration-Dependent Protection by Captopril Against Myocardial Damage During Ischemia and Reperfusion in a Closed Chest Pig ModelJournal of Cardiovascular Pharmacology, 1987
- Beneficial Effects of the Converting Enzyme Inhibitor, Ramipril, in Ischemic Rat HeartsJournal of Cardiovascular Pharmacology, 1986
- Tissue Plasminogen Activator (t-PA)New England Journal of Medicine, 1985
- Use of signals in the terminal QRS complex to identify patients with ventricular tachycardia after myocardial infarction.Circulation, 1981
- Pre- and postjunctional inhibition of vascular sympathetic function by captopril in SHR. Implication of vascular angiotensin II in hypertension and antihypertensive actions of captopril.Hypertension, 1981